2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why?
2017; BMJ; Volume: 77; Issue: 11 Linguagem: Inglês
10.1136/annrheumdis-2017-212701
ISSN1468-2060
Autores Tópico(s)Parkinson's Disease and Spinal Disorders
ResumoThe publication of the EULAR/ACR classification criteria for ‘idiopathic inflammatory myopathy’ group of disease would be considered a landmark work in this field.1 The tremendous efforts of a large number of dedicated workers in the field of myositis from around the world coming together to produce this seminal document deserve high praise. The hope is that it will aid the drug trials on homogeneous subsets of this group of diseases yielding meaningful results. However, there is some concern for ‘an outsider’, a general rheumatologist like me, for not putting more emphasis on myositis-specific antibodies (MSAs). Most of the authors of this document …
Referência(s)